Robot-assisted surgery for bile duct cancer
Part of Cancer clinical trials.
This study tests whether robot-assisted surgery is safe and effective for people with perihilar cholangiocarcinoma (a type of bile duct cancer). It may be a good fit for patients whose cancer has not spread and who are healthy enough for major surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a confirmed or highly suspected bile duct cancer (called perihilar cholangiocarcinoma).
- You have had a CT scan of your belly with contrast dye to check the cancer's stage.
- You understand the study and are willing to follow its rules.
- You can give written permission (informed consent) to take part.
- Your doctors plan to treat the cancer with the goal of curing it (curative intent), following official guidelines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies liver transplantation to treat a specific bile duct cancer (perihilar cholangiocarcinoma) that cannot be removed by surgery. It aims to see if a transplant can help when standard chemotherapy has kept the cancer stable.
This trial tests whether a liver transplant can help people with a specific type of bile duct cancer (perihilar) that cannot be removed with surgery. It aims to offer a potential cure for those whose tumor is small and hasn't spread.
This trial tests whether giving chemotherapy (gemcitabine and cisplatin) combined with immunotherapy (pembrolizumab) before and after surgery can improve outcomes compared to having surgery right away. It is for people with bile duct cancer that can be removed or is borderline removable.
This trial studies liver transplantation for people with a specific type of bile duct cancer near the liver that cannot be safely removed by surgery. It aims to improve outcomes by offering a transplant after the cancer responds to chemotherapy and spread has been ruled out on scans.
This trial tests whether receiving chemotherapy (cisplatin, gemcitabine, and nab-paclitaxel) before surgery can improve outcomes for people with high-risk bile duct or gallbladder cancer. It compares this approach to going straight to surgery.
This study looks at whether robot-assisted pancreaticoduodenectomy (a major operation to remove part of the pancreas and nearby ducts) is safe and effective for people with certain tumors in the pancreas head and nearby areas. If you qualify, your surgery approach and outcomes will be closely tracked to see how well this robotic method works.
Hear when a new Cholangiocarcinoma Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.